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Cognitive changes in patients treated for Obstructive Sleep Apnea with upper airway 
stimulation, maxillomandibular advancement, or expansion sphincter pharyngoplasty 
Nicolas Zingas, Colin Huntley*, Matthew Stewart, Ramez Phillips 
(*) indicates primary project advisor 
Introduction:  Obstructive sleep apnea (OSA) is a prevalent diagnosis that has been shown to 
not only affect sleepiness, but daytime cognitive function — specifically attention, working 
memory, and executive function. CPAP treatment is troublesome for some patients and it is 
possible that superior treatment options, specifically novel surgical techniques, are available, 
though none have been evaluated for their long-term effects on neurocognition. We hypothesize 
that treating patients with upper airway stimulation surgery (UAS) UAS, maxillomandibular 
advancement surgery (MMA), and expansion sphincter pharyngoplasty surgery (ESP) for OSA 
produces a significant improvement in cognition from baseline.  
Methods: For inclusion in the study, two important criteria must be met: 1) a previous diagnosis 
of OSA 2) patients have failed CPAP. Exclusion criteria include pediatric population (<18 years 
of age), and those without ability to complete the NIH Toolbox assessment on an iPad in 
English. Using the iPad-based NIH Toolbox assessment, the primary outcome of the study is to 
analyze the effect of UAS, MMA, and ESP treatment on three markers of cognition: the 
Processing Speed Test, the Inhibitory Control and Attention Test, and Sorting Working Memory 
Test (15 minutes total).  
Results: Data reported below is for one timepoint for nine patients receiving UAS:  
▪ Age=53.8 ± 15.4 
▪ BMI=29.2 ± 4.2 
▪ Depression diagnosis:3/9 
▪ CCI > 0: 5/9 
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▪ Age-adjusted national percentiles:  
▪ Processing speed: 61.4±43.7 
▪ Inhibitory Control and Attention Test: 59.1±32.3  
▪ Sorting Working Memory Test: 52.8±23.7 
 
Discussion: The results of this study will give providers additional information in evaluating 
treatment options for patients with cognitive deficit related to OSA. The gold standard for 
assessing neurocognitive function is fMRI, as demonstrated by studies done showing 
improvement in CPAP patients. Success in this study may support further research using fMRI 
data to support the hypothesis of improvement in cognition. 
